CSIMarket
 
Clearpoint Neuro Inc   (CLPT)
Other Ticker:  
 
 
Price: $11.6200 $0.82 7.593%
Day's High: $11.66 Week Perf: 6.51 %
Day's Low: $ 10.66 30 Day Perf: -1.86 %
Volume (M): 203 52 Wk High: $ 13.47
Volume (M$): $ 2,359 52 Wk Avg: $7.17
Open: $10.76 52 Wk Low: $4.05



 Market Capitalization (Millions $) 319
 Shares Outstanding (Millions) 27
 Employees 77
 Revenues (TTM) (Millions $) 28
 Net Income (TTM) (Millions $) -18
 Cash Flow (TTM) (Millions $) 6
 Capital Exp. (TTM) (Millions $) 0

Clearpoint Neuro Inc
Clearpoint Neuro Inc. is a medical technology company that focuses on developing and commercializing innovative solutions for neurosurgery and neurology. The company's main product is the ClearPoint Neuro Navigation System, a platform used to perform minimally invasive brain surgeries with real-time MRI guidance.

ClearPoint's system provides precise targeting and visualization during brain procedures, enabling surgeons to perform interventions with increased accuracy and safety. The company's technology is utilized in a range of neurosurgical applications such as biopsies, ablations, and electrode implantations for deep brain stimulation.

ClearPoint also offers a software suite called ClearTrace, which provides real-time monitoring and analysis of brain tissue during procedures. This software assists in optimizing therapeutic interventions and improves patient outcomes.

ClearPoint Neuro Inc. is dedicated to advancing the field of neurosurgery by improving patient care and facilitating the development of new therapies. They collaborate with leading medical centers, researchers, and technology companies to drive innovation and support the growth of the neurosurgical field.


   Company Address: 120 S. Sierra Ave. Solana Beach 92075 CA
   Company Phone Number: 287-9109   Stock Exchange / Ticker: NASDAQ CLPT


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Management Announcement

ClearPoint Neuro Achieves Debt-Free Status with Early Repayment of $10 Million Note,

Published Mon, Aug 26 2024 8:06 PM UTC

ClearPoint Neuro Achieves Debt-Free Status with Early Repayment of $10 Million Note
ClearPoint Neuro, a leading therapeutic neuro-navigation system provider, has made a significant stride towards improving its financial health by announcing the early repayment of a $10 million convertible note, held by PTC Therapeutics. This repayment marks a pivotal moment for ClearPoin...

Partnership

ClearPoint Neuro Celebrates Milestone as Partner Aspen Neuroscience Implements ClearPoint Navigation System for ASPIR...

Published Thu, Jun 20 2024 12:45 PM UTC

ClearPoint Neuro, a global leader in intraoperative neurosurgical planning and navigation solutions, is pleased to announce a significant milestone achieved by its valued partner, Aspen Neuroscience. The renowned ClearPoint Navigation System will be utilized for all enrolled patients participating in Aspen's groundbreaking ASPIRO clinical trial. This trial aims to evaluate t...

Product Service News

ClearPoint Neuro, a leading provider of innovative medical devices for neurol...

Published Sat, Jun 1 2024 1:00 PM UTC

Rapid Advances in Neurosurgical Technology Drive Revenue Growth for ClearPoint Neuro Inc. ClearPoint Neuro, a leading provider of innovative medical devices for neurological procedures, recently announced the full market release of two groundbreaking technologies - the SmartFrame OR and the Prism Laser Therapy System. These products, designed to enhance precision and improve...

Clearpoint Neuro Inc

Clearpoint Neuro Inc's Remarkable Financial First Quarter of 2024


As an avid observer of the financial markets, I have come across many intriguing stories and industry revolutions. However, there are few as captivating as ClearPoint Neuro Inc., the medical equipment and supplies company that has become a prominent player in the world of gene and cell therapy research. With their recent financial results painting a picture of growth and innovation, ClearPoint Neuro is poised for an exciting future.
In the most recent fiscal period, ClearPoint Neuro Inc showcased an impressive performance, with a marked improvement in their financial figures. The company decreased their loss per share from -$0.23 to -$0.16, a noteworthy achievement in itself. Additionally, their earnings per share saw a positive shift from -$0.19 to -$0.16 per share from the preceding reporting period.

Product Service News

ClearPoint Neuro Makes Revolutionary Strides in Surgery and Drug Delivery: A Forecast of Anticipated Growth

Published Thu, May 2 2024 8:05 PM UTC

ClearPoint Neuro, Inc., a leading innovator in bio-navigational systems, has firmly positioned itself at the forefront of gene and cell therapy research with groundbreaking projects. Preeminent among these are novel drug delivery research and a pioneering stereotactic system. ClearPoint Neuro's insightful ventures, snaking through the 27th American Society of Gene & Cell The...







Clearpoint Neuro Inc's Segments

  Clearpoint Neuro Inc Outlook

On January 8 2024 the Clearpoint Neuro Inc provided following guidance

ClearPoint Neuro, Inc., a global therapy-enabling platform company that specializes in providing navigation and ...





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com